Last reviewed · How we verify

administration of sufentanil

University Hospital Schleswig-Holstein · Phase 1 active Small molecule Quality 3/100

administration of sufentanil is a Small molecule drug developed by University Hospital Schleswig-Holstein. It is currently in Phase 1 development.

At a glance

Generic nameadministration of sufentanil
SponsorUniversity Hospital Schleswig-Holstein
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about administration of sufentanil

What is administration of sufentanil?

administration of sufentanil is a Small molecule drug developed by University Hospital Schleswig-Holstein.

Who makes administration of sufentanil?

administration of sufentanil is developed by University Hospital Schleswig-Holstein (see full University Hospital Schleswig-Holstein pipeline at /company/university-hospital-schleswig-holstein).

What development phase is administration of sufentanil in?

administration of sufentanil is in Phase 1.

Related